Mario Vega

Columbia University, New York Hospital Queens

Papers

2

Total Citations

49

H-Index

2

About

Dr. Mario Vega is a leading gynecologic oncologist whose research focuses on advancing minimally invasive surgical techniques for the treatment of gynecologic malignancies. His work has been instrumental in evaluating the comparative effectiveness of robotic-assisted laparoscopic surgery (RALS) versus conventional laparoscopic surgery (CLS), particularly in the management of ovarian, fallopian tube, primary peritoneal, and endometrial cancers. Dr. Vega’s most influential study, a 2014 analysis with 46 citations, systematically compared perioperative outcomes and complication rates across early, advanced, and recurrent stages of ovarian and related cancers, providing critical evidence for surgical decision-making. He further contributed a 2019 retrospective analysis of a prospectively maintained database, specifically examining perioperative outcomes in endometrial cancer patients undergoing RALS versus CLS. Through these investigations, Dr. Vega has helped clarify the potential benefits and risks of robotic assistance in complex oncologic surgeries, directly impacting clinical practice and patient care. His work remains a valuable resource for surgeons and researchers seeking to optimize surgical approaches and improve outcomes for women with gynecologic cancers.

Research Focus

Key Achievements

2
H-Index
2
Papers
49
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Perioperative Outcomes and Complication Rates Between Conventional Versus Robotic-Assisted Laparoscopy in the Evaluation and Management of Early, Advanced, and Recurrent Stage Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
46 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Columbia University, New York Hospital Queens

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago